These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 20123717

  • 1. Toll-like receptor 3 agonist protection against experimental Francisella tularensis respiratory tract infection.
    Pyles RB, Jezek GE, Eaves-Pyles TD.
    Infect Immun; 2010 Apr; 78(4):1700-10. PubMed ID: 20123717
    [Abstract] [Full Text] [Related]

  • 2. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K, Mann BJ, Qin A, Barry EM, Ernst RK, Vogel SN.
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
    [Abstract] [Full Text] [Related]

  • 3. Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody.
    Klimpel GR, Eaves-Pyles T, Moen ST, Taormina J, Peterson JW, Chopra AK, Niesel DW, Carness P, Haithcoat JL, Kirtley M, Nasr AB.
    Vaccine; 2008 Dec 09; 26(52):6874-82. PubMed ID: 18930100
    [Abstract] [Full Text] [Related]

  • 4. Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis.
    Chen W, KuoLee R, Shen H, Bùsa M, Conlan JW.
    Microb Pathog; 2004 Oct 09; 37(4):185-91. PubMed ID: 15458779
    [Abstract] [Full Text] [Related]

  • 5. Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy.
    Shen H, Harris G, Chen W, Sjostedt A, Ryden P, Conlan W.
    PLoS One; 2010 Oct 12; 5(10):e13349. PubMed ID: 20967278
    [Abstract] [Full Text] [Related]

  • 6. Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis.
    Troyer RM, Propst KL, Fairman J, Bosio CM, Dow SW.
    Vaccine; 2009 Jul 16; 27(33):4424-33. PubMed ID: 19490961
    [Abstract] [Full Text] [Related]

  • 7. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
    Bakshi CS, Malik M, Mahawar M, Kirimanjeswara GS, Hazlett KR, Palmer LE, Furie MB, Singh R, Melendez JA, Sellati TJ, Metzger DW.
    Vaccine; 2008 Sep 26; 26(41):5276-88. PubMed ID: 18692537
    [Abstract] [Full Text] [Related]

  • 8. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD, Singh R, Metzger DW.
    Infect Immun; 2007 May 26; 75(5):2152-62. PubMed ID: 17296747
    [Abstract] [Full Text] [Related]

  • 9. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R, Harris G, Conlan JW, Chen W.
    Vaccine; 2007 May 10; 25(19):3781-91. PubMed ID: 17346863
    [Abstract] [Full Text] [Related]

  • 10. Neisseria meningitidis PorB, a Toll-like receptor 2 ligand, improves the capacity of Francisella tularensis lipopolysaccharide to protect mice against experimental tularemia.
    Chiavolini D, Weir S, Murphy JR, Wetzler LM.
    Clin Vaccine Immunol; 2008 Sep 10; 15(9):1322-9. PubMed ID: 18614668
    [Abstract] [Full Text] [Related]

  • 11. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q, Bowen R, Lee BY, Dillon BJ, Masleša-Galić S, Horwitz MA.
    Vaccine; 2016 Sep 22; 34(41):4969-4978. PubMed ID: 27577555
    [Abstract] [Full Text] [Related]

  • 12. Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection.
    Gentry M, Taormina J, Pyles RB, Yeager L, Kirtley M, Popov VL, Klimpel G, Eaves-Pyles T.
    Infect Immun; 2007 Aug 22; 75(8):3969-78. PubMed ID: 17502386
    [Abstract] [Full Text] [Related]

  • 13. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
    Twine S, Shen H, Harris G, Chen W, Sjostedt A, Ryden P, Conlan W.
    Vaccine; 2012 May 21; 30(24):3634-45. PubMed ID: 22484348
    [Abstract] [Full Text] [Related]

  • 14. Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.
    Cong Y, Yu JJ, Guentzel MN, Berton MT, Seshu J, Klose KE, Arulanandam BP.
    Vaccine; 2009 Sep 18; 27(41):5554-61. PubMed ID: 19651173
    [Abstract] [Full Text] [Related]

  • 15. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J, Shen H, Kuolee R, Zhao X, Chen W.
    Vaccine; 2005 Mar 31; 23(19):2477-85. PubMed ID: 15752834
    [Abstract] [Full Text] [Related]

  • 16. TLR-dependent control of Francisella tularensis infection and host inflammatory responses.
    Abplanalp AL, Morris IR, Parida BK, Teale JM, Berton MT.
    PLoS One; 2009 Nov 20; 4(11):e7920. PubMed ID: 19936231
    [Abstract] [Full Text] [Related]

  • 17. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.
    Conlan JW, Shen H, Golovliov I, Zingmark C, Oyston PC, Chen W, House RV, Sjöstedt A.
    Vaccine; 2010 Feb 17; 28(7):1824-31. PubMed ID: 20018266
    [Abstract] [Full Text] [Related]

  • 18. Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.
    Ray HJ, Cong Y, Murthy AK, Selby DM, Klose KE, Barker JR, Guentzel MN, Arulanandam BP.
    Clin Vaccine Immunol; 2009 Apr 17; 16(4):444-52. PubMed ID: 19211773
    [Abstract] [Full Text] [Related]

  • 19. Role of neutrophils and NADPH phagocyte oxidase in host defense against respiratory infection with virulent Francisella tularensis in mice.
    KuoLee R, Harris G, Conlan JW, Chen W.
    Microbes Infect; 2011 May 17; 13(5):447-56. PubMed ID: 21277990
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis.
    Kirimanjeswara GS, Golden JM, Bakshi CS, Metzger DW.
    J Immunol; 2007 Jul 01; 179(1):532-9. PubMed ID: 17579074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.